Sterling Investment Advisors (Pennsylvania)’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Hold
9,918
0.04% 216
2026
Q1
$217K Sell
9,918
-1,147
-10% -$25.5K 0.04% 198
2025
Q4
$238K Hold
11,065
0.04% 188
2025
Q3
$130K Hold
11,065
0.03% 196
2025
Q2
$103K Hold
11,065
0.02% 181
2025
Q1
$74.5K Hold
11,065
0.02% 173
2024
Q4
$118K Hold
11,065
0.03% 161
2024
Q3
$162K Hold
11,065
0.04% 150
2024
Q2
$134K Sell
11,065
-1,400
-11% -$21.9K 0.04% 137
2024
Q1
$308K Sell
12,465
-4,500
-27% -$91.3K 0.09% 119
2023
Q4
$182K Buy
+16,965
New +$141K 0.06% 131
2023
Q3
Sell
-21,627
Closed -$171K 142
2023
Q2
$171K Hold
21,627
0.06% 133
2023
Q1
$108K Hold
21,627
0.04% 131
2022
Q4
$47.8K Hold
21,627
0.02% 135
2022
Q3
$96K Hold
21,627
0.04% 138
2022
Q2
$69K Hold
21,627
0.02% 204
2022
Q1
$123K Hold
21,627
0.03% 176
2021
Q4
$280K Hold
21,627
0.08% 126
2021
Q3
$527K Hold
21,627
0.16% 110
2021
Q2
$374K Buy
+21,627
New +$478K 0.11% 122

Other funds holding IMNM

Sterling Investment Advisors (Pennsylvania)'s IMNM Position: Q2 2026 in Review

Sterling Investment Advisors (Pennsylvania) held its Immunome (IMNM) position steady in Q2 2026 at 9,918 shares worth $210K. The position accounts for 0.04% of the portfolio, ranked #216.

Sterling Investment Advisors (Pennsylvania) first reported a position in IMNM in Q2 2021 and has held it in 20 quarters since. The position peaked at $527K in Q3 2021. 26 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Sterling Investment Advisors (Pennsylvania) held 9,918 shares of Immunome worth $210K as of Q2 2026.
  • Sterling Investment Advisors (Pennsylvania) left its Immunome share count unchanged in Q2 2026.
  • Immunome made up 0.04% of Sterling Investment Advisors (Pennsylvania)'s portfolio in Q2 2026, its #216 holding.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Immunome in Q2 2021 and has held it in 20 quarters since.
  • Sterling Investment Advisors (Pennsylvania)'s Immunome position peaked at $527K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 28 Jul 2026.